New German Medical Cannabis Restrictions Will Harm Patients And Hinder Industry Growth (Op-Ed)

New German Medical Cannabis Restrictions Will Harm Patients And Hinder Industry Growth (Op-Ed)

“Despite significant and stable market growth, certain proposed policy changes that have been drafted may hinder industry progress and restrict patient access.” By Niklas Kouparanis, Bloomwell Group A new threat looms over the burgeoning medical cannabis market in Germany. Recently, the German Health Ministry released a draft amendment that would require patients to have an in-person consultation annually and would bar prescriptions from being d…

German Cannabis Advocates Push Back On Harmful Amendment

Germany’s medical cannabis community is resiliant, as demonstrated by swift and largely united pushback from medical cannabis advocates against a recently published draft amendment to the country’s Medical Cannabis Act (MedCanG). The changes are being proposed by Germany’s Ministry of Health despite the effectiveness and safety of telemedicine services. As drafted, the amendment would negatively […] The post German Cannabis Advocates Push Back O…